CCO Slideset

Multitargeted Tyrosine Kinase Inhibitors: Clinical Advances, Synergistic Approaches, and Future Development


Source: Translating Science Into Clinical Practice: Recent Lessons in EGFR Inhibition, Multitargeted TKIs, and the Tumor Microenvironment


Ezra Cohen MD, FRCPC, gives an update on the use of multitargeted tyrosine kinase inhibitors approved for the treatment of a variety of cancers, and provides an overview of mTKIs in clinical development.


Format: Microsoft PowerPoint (.ppt) | File size: 2.08 MB | Date posted: 6/12/2008


*You must be logged into the clinicaloptions.com site to view or save the slides.

Users are encouraged to use these slides in their own presentations, but we ask that content and attribution not be changed. Users are asked to honor this intent. These slides may not be published or posted online without permission from Clincal Care Options.